Council for Tobacco Research
"Site Visit with Dr. George Weinbaum and Staff at the Graduate Hospital [Report]
Fields
- Type
- PA
- 60037438-7442
- Author
- Nov.21
- Depository Date
- Ford Dh, Ctr
- Stone D, Ctr
- Date Loaded
- Abrams
- Damiano
- Weinbaum G, Graduate Hospital Philadelphia
- Damiano
- Named Person
- 264
- Litigation
- Mnag
- Master ID
- 4
Related Documents:- 11281108-1108 ""Captive Youth Population" the Devereaux Foundation at Devon
- 11316828-6828 ""Lung Cancer Among Non and Occasional Cigarette Smokers"
- 11331778-1778 "#12687
- 60012328-2329 "Subgroup Specialty Symposium on "Endothelial Cell Heterogeneity and Organspecificity" at the Annual Meeting of the American Society for Cell Biology
- 60012328-2329_D1 "Subgroup Specialty Symposium on "Endothelial Cell Heterogeneity and Organspecificity" at the Annual Meeting of the American Society for Cell Biology
- 60012654-2654 "Subgroup Specialty Symposium on "Endothelial Cell Heterogeneity and Organspecificity" at the Annual Meeting of the American Society for Cell Biology
- 60012654-2654_D1 "Subgroup Specialty Symposium on "Endothelial Cell Heterogeneity and Organspecificity" at the Annual Meeting of the American Society for Cell Biology
- 60015655-5655 ""Environmental and Genetic Factors in Alzheimer's Disease and Related Disorders: Influences and Interactions
- 60015655-5655_D1 ""Environmental and Genetic Factors in Alzheimer's Disease and Related Disorders: Influences and Interactions
- 60033264-3264 "Eric Stanbridge
- 60033452-3452 "Patrick Bender
- 60034152-4152 "Grant Application No.1638 Joseph Locker
- 60036836-6836 "Site Visit with Dr. Carol Greider
- 60036837-6837 "Site Visit with Dr
- 60036838-6839 "Site Visit with Dr. E.E. Marcantonio
- 60036842-6842 "Site Visit with Dr. K. Calame
- 60036848-6849 "Site Visit with Dr. James Trimmer
- 60036853-6853 "Site Visit with Dr. Srilata Bagchi
- 60036854-6854 "Site Visit with Dr. Victor Engelhard
- 60036856-6856 "Site Visit with Dr. William Petri
- 60036857-6858 "Site Visit with Dr. Katherine Hajjar
- 60036859-6859 "Site Visit with Dr. Howard Lieberman
- 60036860-6860 "Site Visit with Dr. Richard Anderson
- 60036862-6862 "Site Visit with Dr. Colin Jefcoate
- 60036863-6863 "Site Visit with Dr. Lorna Role
- 60036864-6864 "Site Visit with Dr. R. Costa
- 60036865-6866 "Site Visit with Dr. Abel Lajtha and Colleagues at the Nathan Kline Research Institute
- 60036867-6867 "Site Visit with Dr. L. Symington
- 60036874-6874 "Site Visit with Dr. M. Davitz
- 60036881-6881 "Site Visit with Dr. E.E. Marcantonio
- 60036884-6885 "Site Visit with Dr. D. W. Christianson
- 60036892-6892 "Site Visit with Dr. D.Helfman
- 60036900-6900 "Site Visit with Dr. Paula Enrietto
- 60036904-6904 "Site Visit with Dr. Susan Astrin
- 60036905-6905 "Site Visit with Dr. D. Weiner
- 60036906-6906 "Site Visit with Dr. Gary Yellen
- 60036916-6916 "Site Visit with Dr. S.A. Wells
- 60036917-6917 "Site Visit with Dr. M. Nahm
- 60036922-6922 "Site Visit with Dr. Richard Wright
- 60036923-6923 "Site Visit with Dr. L.J. Wysocki
- 60036939-6939 "Site Visit with Dr. S. Lanier
- 60036945-6945 "Site Visit with Dr. R. Palazzo
- 60036949-6949 "Site Visit with Dr. J. Jesty
- 60036964-6964 "Site Visit with Dr. Ronald Lucas
- 60036967-6967 "Site Visit with Dr. S. Naylor
- 60036978-6978 "Site Visit with Dr. T. Vickroy
- 60036994-6994 "Site Visit with Dr. I. Goldberg
- 60036995-6995 "Site Visit with Dr. S. Goyert
- 60036996-6998 "Site Visit with Dr. J. Jesty
- 60037002-7003 "Site Visit with Dr. R. Lewis
- 60037017-7018 "Site Visit with Dr. Fleur Strand
- 60037048-7049 "Site Visit with Dr. Albers
- 60037056-7056 "Site Visit with Dr. J. Edwin Blalock [Graphics]
- 60037067-7069 "Site Visit with Dr. J. Jesty [Graphics]
- 60037072-7073 "Site Visit with Dr. Lajtha and Sershen at Ward's Island
- 60037074-7075 "Site Visit with Dr. J. Lindstrom [Report]
- 60037081-7082 "Site Visit with Dr. S-K. Oh [Report]
- 60037085-7086 "Site Visit with Dr. Y. Osawa [Report]
- 60037091-7091 "Site Visit with Dr. W. Rice [Report]
- 60037101-7101 "Site Visit with Dr. L. Villa-Komaroff [Report]
- 60037102-7104 "Site Visit with Dr. J. Weisz and Dr. Bui [Graphics]
- 60037110-7110 "Site Visit with Dr. J.C. Taylor [Report]
- 60037113-7118 "Site Visit with Drs. N.D. Staub and R. Conhaim [Chart]
- 60037122-7122 "Site Visit September 1984 with B.M. Peterlin [Graphics]
- 60037125-7126 "Site Visit with Dr. A. Mclaughlin [Report]
- 60037137-7138 "Site Visit with Dr. H.P. Jones [Report]
- 60037151-7152 "Site Visit 8/22/84 R.W. Colman
- 60037166-7168 "Site Visit Edward Bresnick [Graphics]
- 60037201-7202 "Site Visit with Dr. D. Cines [Report]
- 60037233-7234 "Site Visit with Dr. D. Buchhagen
- 60037237-7238 "Site Visit with Dr. I. Damjanov
- 60037267-7269 "Site Visit with Dr. J.A. Foster
- 60037292-7295 "Site Visit with Dr. L. Hall at the Albert Einstein College of Medicine [Graphics]
- 60037299-7300 "Site Visit with Dr. L. Hall [Report]
- 60037304-7305 "Site Visit with Dr. R. Huganir [Report]
- 60037340-7342 "Site Visit with Dr. A. Lajtha [Report]
- 60037368-7369 "Site Visit with Dr. Y. Osawa [Report]
- 60037370-7370 "Site Visit with Dr. Mary Osbakken [Report]
- 60037381-7383 "Site Visit with Dr. Repine and Staff [Report]
- 60037395-7396 "Site Visit with Dr. V. Richmond [Report]
- 60037397-7399 "Site Visit with Dr. E. Roberts and Staff at the City of Hope Hospital in Duarte [Report]
- 60037405-7406 "Site Visit with Dr. Regina Santella [Report]
- 60037427-7428 "Site Visit with Dr. F. Strand and Colleagues [Report]
- 60037481-7483 "Site Visit with Dr. M. J. Welsh [Report]
- 60037489-7491 "Site Visit with Dr. J. Bennett [Report]
- 60037492-7493 "Site Visit with Dr. H.L. Bradlow Rockefeller University [Report]
- 60037508-7508 "Site Visit with Dr. Ingegard Keith [Report]
- 60037509-7509 "Site Visit with Dr. Ingegard Keith [Report]
- 60037519-7520 "Site Visit with Dr. M. Osbakken [Report]
- 60038023-8023 "David W. Christianson
- 60040214-0214 "Winter "Think Tank" Meeting Scientific Advisory Board the Council for Tobacco Research-U.S.A. [List]
- 60040380-0380 "Site Visit with Dr. J. Edwin Blalock [Report]
- 60040383-0383 "Site Visit with Dr. W. Rice [Report]
- 60040386-0387 "Site Visit with Dr. M. Gershon [Report]
- 60040391-0391 "Site Visit with Dr Albers [Report]
- 60040395-0396 "Site Visit with Drs Lajtha and Sershen at Ward's Island [Report]
- 60040408-0408 "Site Visit with Dr. L. Villa-Komaroff [Report]
- 60040409-0410 "Site Visit with Dr. S-K. Oh [Report]
- 60040411-0412 "Site Visit with Dr. J. Jesty [Report]
- 60040414-0415 "Site Visit with Dr. Y. Osawa [Report]
- 60040420-0422 "Site Visit with Dr. J. Wiesz and Dr. Bui [Report]
- 60040446-0446 "Site Visit with Dr. Ronald Lucas [Report]
- 60040447-0447 "Site Visit with Dr. S. Naylor [Report]
- 60040451-0451 "Site Visit with Dr. T. Vickroy [Report]
- 60040452-0453 "Site Visit with Dr. E.M. Meyer [Report]
- 60040465-0465 "Site Visit with Dr. S. Lanier [Report]
- 60040472-0472 "Site Visit with Dr. R. Palazzo [Report]
- 60040474-0474 "Site Visit with Dr. J.S. Lipsick [Report]
- 60040475-0475 "Site Visit with Dr. J. Jesty [Report]
- 60040492-0492 "Site Visit with Dr. G. Serrero [Report]
- 60040493-0493 "Site Visit with Dr. Paul Hagerman [Report]
- 60040496-0496 "Site Visit with Dr. Richard Wright [Report]
- 60040499-0499 "Site Visit with Dr. M. Nahm [Graphics]
- 60040500-0500 "Site Visit with Dr. S.A. Wells [Report]
- Recipient
- 1985 Grant, N.O. 1604r2 Entitled "The Role, O.F. Peptide Methionine Sulfoxide Reductase, I.N. Human Lungs: A Possible Defense Against Protein Oxidation And Elastin Degradation, I.N. Smokers.""
- Copied
- 19851126
- Characteristic
- MN Introduces grant that discusses a project which studies elastin degradation in tumor patients in an attempt to understand which factors increase the severity of the disease
- Box
- Memorandum
- Site
- Mar
- Request
- Sommers
- Staff
- SC
- Staff
- Brand
- 19961231
- Gr01604r2
- UCSF Legacy ID
- nrz20a00
Document Images
THE COUNCIL FOR TOBACCO RESEARCH-U.S.A., INC.
November 26, 1985
MEMORANDUM:
TO: Dr. S.C. Sommers and Staff
From: D.H. Ford and D. Stone
Re: Site visit with Dr. George Weinbaiiia and staff at the
Graduate Hospital, Philadelphia, PA, Nov. 21, 1985
Grant No. 1604R2 entitled "The role of peptide
methionine sulfoxide reductase in human lungs: A possible
defense against protein oxidation and elastin degradation in
smokers."
Goal: To determine if the various isozymes of Met
(0)-peptide reductase play an important role in reducing
inactive oCl-PI to the active form to permit it to inactivate
elastase and thus prevent elastin degradation.
Observation: This has been a very productive program
during the year and a half which has elapsed since our last
visit, as evidenced by the attached list of publications (10
since our last visit about a year ago). Progress has been masle
in a number of areas as briefly summarized below.
Results:
I. Use of antibodies to localize elastase and elastin in
tissue by EM immunocytochemistry. Dr. Damiano has developed
techniques which have permitted him to observe that elastase
protein appears first in the ER, in PMN cells. It then
migrates to the Golgi apparatus and then is released into
vesicles which fuse with the plasma membrane to extrude
elastase by exocytosis into the extracellular space, where it
was observed to adhere to elastin, in a patchy manner. In
human lung tissue from patients with emphysema he has observed
interstitial cells (of unknown origin, possibly, derived from
fibroblasts) to contain material which is immunologically
positive as elastase, which follows the same organelle course
as in the PMN cell, and is released into the extracellular
spaces. Quantitative studies on EM sections demonstrated in 8
patients (had lung resections because of tumors) that the
degree of development of emphysema was positively correlated
with the amount of elastase shown to be in association with the
elastin.
II Animal studies performed with rats and with dogs exposed
to smoke or treated with chloramine-T
These studies confirm the observations that smoke exposure
recruits PMNs to the lung. As PMNs pass through the
interstitial tissue they degranulate and the elastase appears
to then associate with the elastin.

-2-
Some elastase released is taken by macrophages, thus adding
to the indigenous macrophage elastase, which appears to be
unaffected by oc 1-PI. How much the macrophage elastase
contributes to the breakdown of elastin is unknown, however.
No2 exposure also recruits PMNs. Under these circumstances
the PMNs also lose their elastase, but it is not known where.
Chloramine -T given intravenously also causes elastin
degradation, because it interferes with normal activity of
al-PI to inactivate elastase. Once elastase degradation of
elastin has started, by whatever means, elastin degradation
appears to continue even though the causative factors may no
longer be operative. Do some of the peptide fragments of
elastin produced by degradation act as signals to further
recruitment of PMNS or is macrophage elastin now involved?
A number of other studies were reported which cumulatively
implicate the PMN as a major contributer to the release of
elastase in lung tissue with the subsequent degradation of
elastin. Weinbuam et al are improving their assays for
detecting additional peptide fragments of elastin in plasma,
Since urinary desmosine assays are not a specific or
quantitative index of pulmonary elastin breakdown, they are
also refining their EM, immunocytochemistry to quantitate the
degree of association of released elastase with elastin in
relation to exposure to toxic agents.
III Met (0)-peptide reductase: A few years ago,when this
enzyme was intitially described by Abrams and others, it was
thought that it might comtribute to the emphysema picture by
serving to reactivate the oxidized methionine molecule formed
when « 1-PI is exposed to oxidants. Although the reductase will
reduce oxidized oCl-PI in vitro, it now appears that it
probably has little or no effect in vivo in a smoke exposed
animal, since it too is inactivated by exposure to smoke
products. Thus, while this seemed to be an interesting
possible protective mechanism normally present in tissue, it
now seems unlikely that it may contribute significantly to
prevent elastase activity.
Synthetic peptide: A synthetic peptide composed of 19
amino acids with a sequence similur to those from the carboxyl
terminus of troRoelastin has been indentified. Antibodies to
it cross react~elastin peptides released after degradation. Is
this a unique peptide sequence normally found in blood after
elastin degradation by elastase? If so, could it be used to
indentify individuals early on in the development of
emphysema? The gene sequence for this peptide has been
determined. Is it found only in subjects who develop emphysema?
Future aims: Determine in man if the amount of elastin
bound elastase increases with the severity of disease.

-3-
Intitial studies with the 8 tumor patients suggest a postive
correlation. In the dog model, determine how long it takes
after smoke exposure for the levels of elastase in the lung (in
alveolar washes and associated with elastin as determined by EM
immunocytochemistry) to return to normal in relation to how long
it takes for the level of circulating elastin peptides to return
to normal.
Comment: This is a highly integrated morphological and
biochemical program concerned with the causation of emphysema.
Progress from year to year is consistently high. Thus, they are
developing a quantitative morphological picture of the release
of elastase containing granules from PMNs and the association of
the enzyme with elastin. This is being correlated with assays
of ciculating elastin peptides which will be able to be used to
quantitate the degrees of elastase attack on elastin as well as
to determine the severity of lung function in patients.
Preliminary studies suggest that there may be unique amino acid
active center sequences in elastin that are more readily
attacked by elastase. While there are many other laboratory
groups investigating this problem, The Weinbuam group has to be
rated among the best. As such it merit our continued support.
DHF/DS
DHF/mla
